Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
-800
¥ million (variance from full-year operating income forecast)Wording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Financial results presentationQ3 FY20266 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥23,277 million+4.4%
Operating profit¥2,273 million-3.0%
Ordinary income¥2,818 million+18.6%
Net income¥2,175 million+5.6%
Gross Profit Margin73.1 %
Operating profit margin9.8 %
Selling, general and administrative expenses¥14,750 million
Results for the three months of the current quarter
Content business
Net Sales
¥3,957 million
Operating profit
¥1,121 million
Healthcare Business
Net Sales
¥1,902 million
Operating profit
¥-312 million
School DX business
Net Sales
¥624 million
Operating profit
¥231 million
Other Businesses
Net Sales
¥1,493 million
Operating profit
¥206 million
Full-year earnings forecast
Net Sales
¥31,500 million
Operating profit
¥2,700 million
Ordinary income
¥3,100 million
Profit attributable to owners of the parent
¥2,680 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Net Sales
Healthcare and School DX revenue growthDisclosed
Ordinary income
Increase in Equity-Method Investment Income
¥485 million
Selling, general and administrative expenses
Advertising expenses
¥-144 million
Personnel Expenses
¥172 million
Fees paid
¥200 million
Outsourcing expenses
¥208 million
Depreciation and amortization
¥19 million
Other
¥19 million
New initiatives
- Commercialization and launch preparations for the next-generation cloud-based dispensing and prescription records system
- Adding an AI-powered automatic summarization function to the cloud medication-history system
- Promotion of cross-selling of pharmacy DX services
- Expansion of prefecture-level partnerships for LunaLuna Mirai Support
- Expansion of School DX adoption among private and public schools
Key KPIsA metric the company considers important as a management benchmark.
- Stores using the cloud medication-history system (cumulative)4,743 storesQuarter-on-quarter change285
- Paid subscribers to the Content business316 10,000 people
- Paying subscribers to security-related applications131 10,000 people
- Municipalities using Childcare DX services (cumulative)427 Local government
- Municipalities using the maternal and child health handbook app891 Local government
- Number of private schools using the service1,359 schools
- Private-school share50 %
Unit price and quantity metricsThese figures show sales broken down by price and volume.
School DX business
Monthly fee per student
¥300
Revenue compositionNumber of students × monthly fee per student × number of schools using the service
Childcare DX business
Monthly fee for the maternal and child health handbook app
¥50,000–¥100,000
Segment results
Content business
Net Sales
¥12,356 million
Operating profit
¥3,362 million
Healthcare Business
Net Sales
¥5,830 million
Operating profit
¥-566 million
School DX business
Net Sales
¥1,773 million
Operating profit
¥641 million
Other Businesses
Net Sales
¥4,545 million
Operating profit
¥824 million
Market Size / Share
Private-school share
50 %
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Q3 FY2026 |
| Net Sales | ¥23,277 million (YoY +4.4%) |
| Operating profit | ¥2,273 million (YoY -3.0%) |
| Ordinary income | ¥2,818 million (YoY +18.6%) |
| Net income | ¥2,175 million (YoY +5.6%) |
| Gross Profit Margin | 73.1 % |
| Operating profit margin | 9.8 % |
| Selling, general and administrative expenses | ¥14,750 million |
| Results for the three months of the current quarter | Content business Net Sales ¥3,957 million / Operating profit ¥1,121 million / Healthcare Business Net Sales ¥1,902 million / Operating profit ¥-312 million / School DX business Net Sales ¥624 million / Operating profit ¥231 million / Other Businesses Net Sales ¥1,493 million / Operating profit ¥206 million |
| Full-year earnings forecast | Net Sales ¥31,500 million / Operating profit ¥2,700 million / Ordinary income ¥3,100 million / Profit attributable to owners of the parent ¥2,680 million |
| Segment results | Content business Net Sales ¥12,356 million / Operating profit ¥3,362 million / Healthcare Business Net Sales ¥5,830 million / Operating profit ¥-566 million / School DX business Net Sales ¥1,773 million / Operating profit ¥641 million / Other Businesses Net Sales ¥4,545 million / Operating profit ¥824 million |
| Breakdown of Factors Affecting the Change | Net Sales Healthcare and School DX revenue growth Disclosed / Ordinary income Increase in Equity-Method Investment Income ¥485 million / Selling, general and administrative expenses Advertising expenses ¥-144 million / Personnel Expenses ¥172 million / Fees paid ¥200 million / Outsourcing expenses ¥208 million / Depreciation and amortization ¥19 million / Other ¥19 million |
| Key KPIs | Indicator name Stores using the cloud medication-history system (cumulative) / Value 4,743 stores / Year on year against the same period last year Not disclosed / Quarter-on-quarter change 285 stores, Indicator name Paid subscribers to the Content business / Value 316 10,000 people / Year on year against the same period last year Not disclosed, Indicator name Paying subscribers to security-related applications / Value 131 10,000 people / Year on year against the same period last year Not disclosed, Indicator name Municipalities using Childcare DX services (cumulative) / Value 427 Local government / Year on year against the same period last year Not disclosed, Indicator name Municipalities using the maternal and child health handbook app / Value 891 Local government / Year on year against the same period last year Not disclosed, Indicator name Number of private schools using the service / Value 1,359 schools / Year on year against the same period last year Not disclosed, Indicator name Private-school share / Value 50 % / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | School DX business Monthly fee per student ¥300 / Revenue composition Number of students × monthly fee per student × number of schools using the service / Childcare DX business Monthly fee for the maternal and child health handbook app ¥50,000–¥100,000 |
| Market Size / Share | Private-school share 50 % |
| New initiatives | Commercialization and launch preparations for the next-generation cloud-based dispensing and prescription records system, Adding an AI-powered automatic summarization function to the cloud medication-history system, Promotion of cross-selling of pharmacy DX services, Expansion of prefecture-level partnerships for LunaLuna Mirai Support, Expansion of School DX adoption among private and public schools |
Items this document does not state (14)
Progress against full-year forecastSelf-assessment against the planNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Higher development costs ahead of the launch of the next-generation cloud-based dispensing and prescription records system, and higher costs associated with expanding prefecture-level partnership agreements for the “LunaLuna Mirai Support” service. The increase in ordinary income for the cumulative third quarter was attributed to a ¥485 million increase in equity-method investment gains.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.